Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis. Adjunctive therapy to maintenance immunosuppression

American Journal of Respiratory and Critical Care Medicine

Volumn 156, Issue 6, 1997, Pages 1897-1901

  Behr, Jürgen ^a   Maier, Konrad ^b   Degenkolb, Barbara ^b   Krombach, Fritz ^b   Vogelmeier, Claus ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; AZATHIOPRINE; CYCLOPHOSPHAMIDE; GLUTATHIONE; IMMUNOSUPPRESSIVE AGENT; METHIONINE SULFOXIDE; PREDNISOLONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG MIXTURE; FEMALE; FIBROSING ALVEOLITIS; GLUTATHIONE METABOLISM; HUMAN; LUNG FUNCTION TEST; LUNG LAVAGE; MALE; ORAL DRUG ADMINISTRATION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PHAGOCYTE; PRIORITY JOURNAL;

EID: 0031449645     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.156.6.9706065     Document Type: Article

References (33)

1. Cantin, A. M., S. L. North, G. A. Fells, R. C. Hubbard, and R. G. Crystal. 1987. Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis. J. Clin. Invest. 79:1665-1673.
2. Clement, A., K. Chadelat, J. Masliah, B. Housset, A. Sardet, A. Grimfeld, and G. Tournier. 1987. A controlled study of oxygen metabolite release by alveolar macrophages from children with interstitial lung disease. Am. Rev. Respir. Dis. 136:1424-1428.
3. Behr, J., K. Maier, F. Krombach, and B. C. Adelmann-Grill. 1991. Pathogenetic significance of reactive oxygen species in diffuse fibrosing alveolitis. Am. Rev. Respir. Dis. 144:146-150.
4. Cantin, A. M., R. C. Hubbard, and R. G. Crystal. 1989. Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 139:370-372.
5. Strausz, J., J. Müller-Quernheim, H. Steppling, and R. Ferlinz. 1990. Oxygen radical production by alveolar inflammatory cells in idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 141:124-128.
6. MacNee, W., and I. Rahman. 1995. Oxidants/antioxidants in idiopathic pulmonary fibrosis. Thorax 50(Suppl. 1):S53-S58.
7. Weiss, S. J. 1989. Tissue destruction by neutrophils. N. Engl. J. Med. 320: 365-376.
8. Schraufstätter, I. U., and C. G. Cochrane. 1991. Oxidants: types, sources, and mechanisms of injury. In R. G. Crystal and J. B. West, editors. The Lung. Raven Press, New York. 1803-1810.
9. Greenwald, R. A., and W. W. Moy. 1979. Inhibition of collagen gelatin by action of superoxide radical. Arthritis Rheum. 22:251-259.
10. Greenwald, R. A., and W. W. Moy. 1980. Effects of oxygen-derived free radicals on hyaluronic acid. Arthritis Rheum. 23:455-463.
11. Weiss, S. J., G. Peppin, X. Ortiz, C. Ragsdale, and S. T. Test. 1985. Oxidative autoactivation of latent collagenase by human neutrophils. Science 227:747-749.
12. Martin, W. J., II, J. E. Gadek, G. W. Hunninghake, and R. G. Crystal. 1981. Oxidant injury of lung parenchymal cells. J. Clin. Invest. 68:1277-1288.
13. Cantin, A. M., S. L. North, R. C. Hubbard, and R. G. Crystal. 1987. Normal alveolar epithelial lining fluid contains high levels of glutathione. J. Appl. Physiol. 63:152-157.
14. Cantin, A. M., and R. Begin. 1991. Glutathione and inflammatory disorders of the lung. Lung 169:123-138.
15. Behr, J., B. Degenkolb, K. Maier, B. Braun, T. Beinert, F. Krombach, C. Vogelmeier, and G. Fruhmann. 1995. Increased oxidation of extracellular glutathione by bronchoalveolar inflammatory cells in diffuse fibrosing alveolitis. Eur. Respir. J. 8:1286-1292.
16. Smilkstine, M. J., G. L. Knapp, K. W. Kulig, and B. H. Rumack. 1988. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose: analysis of the National Multicenter Study (1976-1985). N. Engl. J. Med. 319:1557-1562.
17. Keays, R., P. M. Harrison, J. A. Wendon, A. Forbes, C. Gove, G. J. Alexander, and R. Williams. 1991. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. B.M.J. 303:1026-1029.
18. Meyer, A., R. Buhl, and H. Magnussen. 1994. The effect of oral N-acetylcysteine on lung glutathione levels in idiopathic pulmonary fibrosis. Eur. Respir. J. 7:431-436.
19. Meyer, A., R. Buhl, S. Kampf, and H. Magnussen. 1995. Intravenous N-acetylcysteine and lung glutathione of patients with pulmonary fibrosis and normals. Am. J. Respir. Crit. Care Med. 152:1055-1060.
20. Crystal, R. G., J. E. Gadek, V. J. Ferrans, J. D. Fulmer, B. R. Line, and G. W. Hunninghake. 1981. Interstitial lung disease: current concepts of pathogenesis, staging and therapy. Am. J. Med. 70:542-568.
21. Rodnan, G. P., S. Jablonska, and T. A. Medsger. 1976. Classification and nomenclature of progressive systemic sclerosis (scleroderma). Clin. Rheum. Dis. 5:5-13.
22. Subcommittee of Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. 1980. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 23:581-590.
23. LeRoy, E. C., C. Black, R. Fleismayer, S. Jablonska, T. Krieg, T. A. Medsger, N. Rowell, and F. Wollheim. 1980. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J. Rheumatol. 15: 202-205.
24. Akerboom, T. P. M., and H. Sies. 1981. Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples. Methods Enzymol. 77:373-382.
25. Adams, J. D., B. H. Lauterburg, and J. R. Mitchell. 1983. Plasma glutathione and glutathione disulfide in the rat: regulation and response to oxidative stress. J. Pharmacol. Exp. Ther. 227:749-754.
26. Sies, H., and T. Akerboom. 1984. Glutathione disulfide (GSSG) efflux from cells and tissue. Methods Enzymol. 105:445-451.
27. Rennard, S. I., G. Basset, D. Lecossier, K. M. O'Donnell, P. Pinkston, P. G. Martin, and R. G. Crystal. 1986. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J. Appl. Physiol. 60:532-538.
28. Maier, K., L. Leuschel, and U. Costabel. 1991, Increased levels of oxidized methionine in BAL fluid proteins from patients with idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 143:271-274.
29. Maier, K. L., A. G. Lenz, I. Beck-Speier, and U. Costabel. 1995. Analysis of methionine sulfoxide in proteins. Methods Enzymol. 251:455-461.
30. Quanjer, P. H., G. J. Tammeling, J. E. Cotes, O. F. Pederson, R. Peslin, and J. C. Yernault. 1993. Lung volumes and forced ventilatory flows: working party standardization of lung function tests. European Community for Steel and Coal. Official statement of the European Respiratory Society. Eur. Respir. J. 6(Suppl. 16):5-40.
31. Ulmer, W. T., G. Reichel, D. Nolte, and M. S. Islam. 1983. Die Lungen-funktion - Physiologie, Pathophysiologie, Methodik. Georg Thieme Verlag, Stuttgart. 104-111.
32. Behr, J., C. Vogelmeier, T. Beinert, M. Meurer, F. Krombach, G. König, and G. Fruhmann. 1996. Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung. Am. J. Respir. Crit. Care Med. 154:400-406.
33. Borok, Z., R. Buhl, G. J. Grimes, A. D. Bokser, R. C. Hubbard, K. J. Holroyd, J. H. Roum, D. B. Czerski, A. M. Cantin, and R. G. Crystal. 1991. Effect of glutathione aerosol on oxidant-antioxidant imbalance in idiopathic pulmonary fibrosis. Lancet 338:215-216.